05-Mar-2014 - The US FDA has approved a weekly single-use syringe for AstraZeneca’ Bydureon as Lilly reveals its ambition in the GLP-1 drug market.
05-Mar-2014 - Addiction doctors have petitioned the US FDA to prevent Zohydro ER, the first single-entity hydrocodone painkiller, hitting the market this month citing its potential for abuse. Its maker, Zogenix, has been tight-lipped on whether the drug’s formulation uses anti-abuse technology.
27-Feb-2014 - European regulators have been accused of making “no attempt” to counter misuse of prescription drugs in comparison with North American efforts to reformulate and restrict addictive drugs, according to a Canadian firm testing the abuse potential of medicines.
25-Feb-2014 - The US FDA on Monday announced in a draft guidance that it’s revising its historical interpretation of the 5-year NCE exclusivity provisions to further incentivize the development of certain fixed-combination products.
18-Feb-2014 - Debate rages over the significance of safety data from a trial of Oramed’s oral insulin pill, but the firm is still confident in its delivery technology.
18-Feb-2014 - Actavis has confirmed it will acquire Forest Laboratories in a deal worth up to $25bn (€18bn) following rumours last night.
17-Feb-2014 - A new study published in the Institute of Physics Science reveals that Chinese researchers have developed gold nanoparticles that may help deliver cancer treatments to specifically targeted cells.
11-Feb-2014 - The National Institutes of Health and 10 pharmaceutical companies have launched a partnership to transform the current model for identifying and validating promising biological targets for Type 2 diabetes, Alzheimer’s disease, lupus and rheumatoid arthritis.
06-Feb-2014 - An increased trend in dealmaking for targeted drug delivery last year will continue to drive partnerships in 2014, according to a pharmaceutical partnering expert.
05-Feb-2014 - Unilife says it expects more contracts for its intravitreal injection technology Ocu-ject following the signing of a major deal last quarter.
03-Feb-2014 - Lupin Ltd has bought Dutch delivery technology company Nanomi BV in a deal that moves the Indian generics firm into the complex injectables space.
30-Jan-2014 - Clarus Therapeutics has submitted to the FDA a testosterone replacement it claims overcomes the toxicity problems that have plagued other oral drugs like methyltestosterone.
27-Jan-2014 - Actavis has announced plans to sell its stake in its Chinese subsidiary just days after telling investors the country is 'too risky' for new investments.
27-Jan-2014 - Par Pharmaceutical Companies has agreed to buy JHP Group Holdings for $490M (€358M) to add sterile injectables to its offering.
23-Jan-2014 - Rexam has completed its extension of a French plant that manufactures the nasal spray pump product, Advancia.
22-Jan-2014 - Teva Pharmaceutical Industries has agreed to acquire NuPathe for $144m (€106m) and gain access to the company’s transdermal patch.
16-Jan-2014 - Complex generics will represent over 50% of Teva’s generic market by 2017, the firm says, but investments in delivery technology will have positive implications across the full business.
14-Jan-2014 - Merck & Co.’s divestiture of its RNA interference business (RNAi) was part of a strategy to cut $2.5bn and focus on core areas, according to its CEO.
13-Jan-2014 - Alnylam has both acquired Merck & Co. subsidiary Sirna therapeutics and extended an alliance with Genzyme in order to advance its small interfering RNA (siRNA) delivery programme.
09-Jan-2014 - A drug delivery technology that ‘shuttles’ molecules across the blood-brain-barrier could have major implications in developing drugs for disorders such as Alzheimer's and Parkinson’s disease, Roche says.
07-Jan-2014 - The US Food and Drug Administration (FDA) is working towards a method to validate the effectiveness and safety of medicated chewing gums such as nicotine gum.
07-Jan-2014 - AstraZeneca says the small molecule cyclin-dependent kinase 9 (CDK9) inhibitor programme acquired from Probiodrug has the potential to target cancer cells.
07-Jan-2014 - Aerogen has licensed its respiratory drug delivery technology to Dutch electronics giant Philips in a deal announced today.
06-Jan-2014 - Injectable device manufacturer Unilife has announced a contract with a pharmaceutical multinational for the use of its Ocu-ject eye syringe, marking its fifth major contract in four months.
17-Dec-2013 - Endo has obtained NuPathe’s transdermal migraine patch and its iontophoresis drug delivery technology as part of the $105m (€76m) acquisition.
A longer than expected upgrade to one of its injectable plants has caused Pfizer to announce that...
Despite splintering into rival companies a century ago, Merck & Co. and Merck KGaA have once again...
Sinopharm expects customer drug launches and its recent investment in cancer injectables to drive revenue gains and...
The US FDA has upgraded Hospira’s troubled Rocky Mount, North Carolina plant to VAI (voluntary action indicated)...
It is too early to predict what impact proposed changes to US rules on chemical plant security...
Pfizer says its ‘off the shelf’ aseptic processing capacity is shifting the paradigm of pharma manufacturing, with...